Psychotropic drugs

Katherine Leah Wisner*, Christof Schaefer

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

5 Scopus citations

Abstract

Women of childbearing age are often affected with depressive, psychotic or other psychiatric disorders, requiring medication during pregnancy. Psychopharmaceuticals during pregnancy constitute both a potential risk to the developing fetus as well as a possible benefit through improvement of the disease state. According to the current knowledge there is no strong teratogen among the classical psychoparmaceuticals. The risk of the mood stabilizer lithium has been confirmed but was overestimated. However, many drugs used in psychiatry are insufficiently tested with respect to their effects on the fetus. Valproic acid should be avoided during pregnancy due to its established physical and neurobehavioral teratogenicity, and it is not a drug of first choice for the management of women of childbearing age. This chapter provides a detailed overview on SSRI and the other antidepressants, on antipsychotics, mood stabilizers, anxiolytics, hypnotics and, among others, on restless legs treatment.

Original languageEnglish (US)
Title of host publicationDrugs During Pregnancy and Lactation
Subtitle of host publicationTreatment Options and Risk Assessment: Third Edition
PublisherElsevier Inc
Pages293-339
Number of pages47
ISBN (Electronic)9780124079014
ISBN (Print)9780124080782
DOIs
StatePublished - Nov 26 2014

Keywords

  • Antidepressants
  • Antipsychotics
  • Anxiolytics
  • Hypnotics
  • Mood stabilizers
  • Neuroleptics
  • Parkinson drugs
  • Pregnancy
  • Restless legs
  • SGA
  • SSRI
  • Sedatives

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Psychotropic drugs'. Together they form a unique fingerprint.

Cite this